腹腔镜盆腔廓清术与侧向扩大盆腔内切除术治疗放疗后复发宫颈癌
PE组均达R0切除,2年无病生存率68.9%、总生存率76%;LEER组R0切除率73%,2年无病生存率27.3%、总生存率29.6%。腹腔镜PE可行且结局可接受,腹腔镜LEER亦可行但肿瘤学结局可能有限。
要点
- 腹腔镜LEER用于侧向复发可行,但R0切除率73%,2年总生存率29.6%。
- 两组均无中转开腹,死亡率均为0%,PE组并发症率41%、LEER组55%。
核心结论
- 腹腔镜PE对放疗后中央型复发宫颈癌可行且结局可接受。
- 腹腔镜LEER对侧向复发亦可行,但肿瘤学结局可能有限。
- 需更大样本和更长随访确定腹腔镜LEER的适应证。
研究设计与样本
- 前瞻性研究,纳入28例放疗后复发宫颈癌患者。
主要发现
- PE组中位手术时间454分钟、出血量285 mL;LEER组分别为562分钟、325 mL,均无中转开腹。
- PE组并发症率41%、死亡率0%;LEER组并发症率55%、死亡率0%。
- PE组2年无病生存率68.9%、总生存率76%;LEER组分别为27.3%、29.6%。
临床怎么用
- 对放疗后中央型复发宫颈癌可考虑腹腔镜PE。
- 腹腔镜LEER可用于侧向复发,但需谨慎选择患者并充分告知肿瘤学结局可能有限。
局限性
- 样本量有限(28例),为初步研究。
- 随访时间较短,需更长随访验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Surgery is the only treatment for cervical cancer recurrence in a previously irradiated field. Pelvic exenteration (PE) and laterally extended endopelvic resection (LEER) are indicated for select patients; however, morbidity and mortality rates remain high, and new treatment modalities are required. Laparoscopy optimizes visualization and allows meticulous dissection while also reducing intraoperative blood loss and postoperative complications without worsening the outcomes. We aimed to clarify the feasibility and outcomes of laparoscopic PE and LEER for previously irradiated recurrent cervical cancer. METHODS: We prospectively investigated the outcomes of laparoscopic PE and LEER in 28 patients with recurrent cervical carcinoma after radiotherapy. RESULTS: Seventeen laparoscopic PEs for central recurrences and 11 laparoscopic LEERs for lateral recurrences were performed. The median operation time and blood loss were 454mins and 285 mL in the PE group, and 562mins and 325 mL in the LEER group, respectively, with no conversions to laparotomy. R0 resection was achieved in all patients in the PE group and 73% in the LEER group. The morbidity and mortality rates were 41% and 0% in PE group, and 55% and 0% in LEER group, respectively. The 2-year disease-free survival and overall survival were 68.9% and 76% in the PE group, and 27.3% and 29.6% in the LEER group, respectively. CONCLUSION: Laparoscopic PE is feasible for previously irradiated central recurrent cervical cancer and has acceptable outcomes. Laparoscopic LEER is also feasible for lateral recurrence, but oncologic outcome may be modest in this limited preliminary study. Further studies using a larger sample size with a longer follow-up period is warranted to determine the indications for laparoscopic LEER.
引用
- Kanao H, Aoki Y, Omi M, et al. Laparoscopic pelvic exenteration and laterally extended endopelvic resection for postradiation recurrent cervical carcinoma: Technical feasibility and short-term oncologic outcome. Gynecol Oncol. 2021. PMID: 33423805. doi:10.1016/j.ygyno.2020.12.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。